Skip to content

Processed Meat and Colon Carcinogenesis

Effect of Processed Meat on Colorectal Carcinogenesis. Study of Mechanisms. Choice of Preventive Strategies

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00994526
Acronym
Hemcancer
Enrollment
18
Registered
2009-10-14
Start date
2009-10-31
Completion date
2010-01-31
Last updated
2012-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Keywords

Colorectal cancer, Processed meat, Calcium, Vitamin E, Preventive strategies

Brief summary

Colorectal cancer kills forty five people in France every day. Epidemiological studies suggest that two cases out of three could be prevented and show that processed meat intake is a consistent risk factor. The aim of this study is to understand how meat promotes cancer, to find protective strategies, and to make compelling dietary recommendations.

Detailed description

18 healthy volunteers will be randomized and will start the study. The study will last 4 weeks for each subject. The first week will be a week of adaptation (or run-in period) to the diet which they will have to follow for the duration of study. During this period, they will collect 2 samples of stools and urine. Then subjects will alternate 4 days of diet either with ham, or with ham and calcium, or with ham enriched with vitamin E. At least, 3 days will separate every period (wash-out) of nutritional intervention. Urines and stools will be collected last 3 days of every interventional period and also last day of every wash out period.

Interventions

OTHERHam

Ham : 180 g per day during 4 days

OTHERHam + calcium

Ham : 160g/d during 4 days calcium : 1000mg/d during 4 days

OTHERHam + vitamin E

Ham : 160g/d during 4 days Vitamin E : 80 mg/d during 4 days

Sponsors

Centre de Recherche en Nutrition Humaine d'Auvergne
CollaboratorOTHER_GOV
Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
MALE
Age
40 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Male * Body mass index 20 \<= BMI \<= 30 kg/m2 * Affiliated to French National Health Insurance * Subject giving his written informed consent * Subject considered as normal after clinical examination and medical questionnaire

Exclusion criteria

* Positive serologies to HIV or HCV, determined on blood samples * Previous medical and/or surgery judged by the investigator as incompatible with this study * Previous familial of colon, ovarian or breast cancer * Chronic pathologies : cardiovascular diseases, cancer, chronic inflammation diseases, renal, intestinal impairments * Dislike ham * Heavy consumer of alcohol * Practising intensive physical exercise * Being under someone's supervision * Refusal to be registered on the National Volunteers Data file * Dietary habits unreliable to controlled food intake * Being in exclusion on the National Volunteers Data file

Design outcomes

Primary

MeasureTime frame
Urinary biomarker (DHN-MA:dihydroxynonene mercapturic acid), will be measured before and after every interventional periodTwice a week, before and after every 4 days of interventional period

Secondary

MeasureTime frame
Fecal biomarkerstwice a week, before and after every 4 days of interventional period

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 22, 2026